Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fore Kopi Indonesia Tbk. (FORE) vs Merck Tbk. (MERK) Price & Performance

Fore Kopi Indonesia Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Fore Kopi Indonesia Tbk. vs Merck Tbk. — how do they compare? Fore Kopi Indonesia Tbk. trades at Rp615 (market cap 5.48T, 200.6K 24h volume), while Merck Tbk. trades at Rp3,820 (market cap 1.7T, 1.3K 24h volume). The key difference: Fore Kopi Indonesia Tbk. is far larger — about 3.2× Merck Tbk.'s market cap, and Fore Kopi Indonesia Tbk. is more actively traded (200.6K versus 1.3K). Which is the better fit depends on your goals.

FOREMERK
Market Cap
5.48T1.7T
Volume
200.6K1.3K
Lot
2.01K13
Turnover
123.18M4.97M
Average Price
614.063,825.38
Value
123.18M4.97M
Indicative Equilibrium Price
6153,850
Indicative Equilibrium Volume
30.9K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

FORE
View details
MERK
View details

About Fore Kopi Indonesia Tbk.

PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.

Read more on FORE

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK